Background
==========

Population-based genetic association analysis is a powerful method for detecting susceptibility loci for complex diseases. A common issue in such design is that it may be subject to population heterogeneity and, as a result, spurious association may be reported if the population substructure is not properly addressed. Many methods have been proposed to deal with population heterogeneity in genetic association analysis.

When there is population stratification (PS) on allele frequencies, a direct method is to use family-based design \[[@B1]-[@B5]\] in which unaffected family members are chosen to match each case so that the association detected is truly due to the linkage between the candidate marker and the disease. But this method is limited by the cost and the difficulty in recruiting family members. Pritchard et al. \[[@B6],[@B7]\] used a Bayesian clustering method to infer the number of subpopulations and to assign the individuals to putative subpopulations. The inferred memberships in each subpopulation are then used to perform tests of association for that subpopulation. A modification of this method was implemented by Satten et al. \[[@B8]\], in which subpopulation memberships were decided by a latent class model. Patterson et al. \[[@B9]\] proposed a principle components analysis method to correct for the population structure and obtained a test statistic based on the eigenvalues of the correlation matrix to detect the population structure. When the population has substructure, the usual chi-square statistics have non-central chi-square distributions under the null. Gorroochurn et al. \[[@B10]\] proposed a δ-centralization method to correct for PS by centralizing the test statistics using information from the null markers.

Another form of population heterogeneity is the cryptic relatedness or correlation across individuals. For this type of data, Devlin and Roeder \[[@B11]\] developed the genomic-control (GC) method to correct for the variance inflation. They proposed to use the additive Cochran-Armitage trend test to detect the gene-phenotype association. Assuming that the correlations or kinship coefficients are the same across all markers, they showed that the scaled test statistic has asymptotically a 1-df chi-square distribution. The scaling factor, known as the variance inflation factor (VIF), can be estimated from information of the unlinked null markers.

The GC method is a simple and effective method in association studies to correct for population heterogeneity caused by cryptic relatedness. However, when the GC method is applied to recessive or dominant trend tests \[[@B12]\] or, to Pearson\'s chi-square test \[[@B13]\] or other robust tests \[[@B14]\], the null loci are required to match with the candidate loci in allele frequencies, which reduces the number of available null makers.

In this study, we propose a regression-based genomic control (RGC) method that can be applied to association tests other than the additive trend test. This method allows for using arbitrary null markers in the GC correction procedure by adjusting the variability of the allele frequencies of the null markers through linear regression. We use simulation studies to check whether the method appropriately corrects for the problem of spurious association. In addition the robustness of the proposed method to the errors in selecting null markers is assessed. We also simulate the power of our method.

Methods
=======

Trend tests
-----------

Let *A*be the high-risk candidate allele with the allele frequency *p*and *a*the normal one with the allele frequency *q*= 1 - *p*. To detect the association between the marker *A*and a disease, we assume that there are *n*~0~cases and *n*~1~controls with total *n*= *n*~0~+ *n*~1~individuals. The genotype data are summarized in Table [1](#T1){ref-type="table"}.

###### 

Genotype counts

            Genotype                       
  --------- ---------- --------- --------- --------
  Case      *n*~00~    *n*~01~   *n*~02~   *n*~0~
  Control   *n*~10~    *n*~11~   *n*~12~   *n*~1~
                                           
  Total     *m*~0~     *m*~1~    *m*~2~    *n*

Denote the three genotypes by *G*~0~= *aa*, *G*~1~= *Aa*and *G*~2~= *AA*. Let *f*~*i*~= *P*(*case\|G*~*i*~) be the penetrance given genotype *G*~*i*~, *i*= 0, 1, 2. The null hypothesis of no association between the candidate marker and a disorder can be expressed as *H*~0~: *f*~0~= *f*~1~= *f*~2~. Since *A*is a high risk allele and *a*a normal one, let the score of genotype *aa*be 0, and that of *AA*be 1. For a specific choice of score *x*for genotype *Aa*, let

be the difference in weighted allele frequency between cases and controls, where = *n*~*ij*~/*n*~*i*~, *i*= 0, 1, *j*= 1, 2. When there is no allelic dependence or Hardy-Weinberg equilibrium holds in the population, Δ~*x*~has, under the null hypothesis, the variance

where *p*~1~and *p*~2~are the frequencies of *Aa*and *AA*respectively. It can be estimated by

where = *m*~*k*~/*n*is the estimate of *p*~*k*~, *k*= 1, 2. The Cochran-Armitage\'s trend test indexed by *x*is then given by

In standard situation, has a central chi-square distribution with one degree of freedom under the null hypothesis. However, if there is cryptic relatedness, may be inflated. Denote the inflated variance of Δ~*x*~under the null by = *var*~*CR*~(Δ~*x*~) and the variance inflation factor by . By this notation, in the presence of CR, *Z*~*x*~\~ *N*(0, *λ*~*x*~) under the null hypothesis. Illustrated in Figure [1](#F1){ref-type="fig"} are the VIF *λ*~0~, *λ*~0.5~and *λ*~1~as a function of the allele frequency *p*of the candidate marker. This figure was drawn from a simulated data of three subpopulations with (20, 30, 50) cases and (50, 30, 20) controls, and the Wright\'s coefficient *F*being 0.01. It shows that *λ*~0.5~of the additive model is a constant, *λ*~1~of a dominant trend test is a decreasing function of *p*while *λ*~0~of a recessive trend test is an increasing function of *p*. This verifies the results in \[[@B12]\].

![**VIF as function of allele frequency p of candidate marker (F = 0.01)**.](1471-2156-10-78-1){#F1}

The fact that the VIF *λ*~0.5~of the additive trend test doesn\'t depend on allele frequency of the candidate marker makes it possible that the *λ*~0.5~can be consistently estimated from a sequence of unlinked markers with arbitrary allele frequencies \[[@B11]\]. Unfortunately this is not true for trend tests with *x*other than 0.5 since the quantity *λ*~*x*~does depend on allele frequency of the candidate marker. Therefore, dominant or recessive trend tests and other robust tests cannot be uniformly adjusted by the GC method using null markers with different allele frequencies. To overcome this problem, Zheng et al. \[[@B12]\] proposed to use null markers that have the same allele frequency as that of the candidate marker to evaluate the variance inflation factor. This constraint of matching allele frequency limits substantially the number of null markers that can be used.

RGC method
----------

In what follows, we propose a regression-based GC method to adjust for the frequency variability of null markers when the GC method is applied to the general trend tests and the Pearson chi-square test.

In the Appendix, we show that when cryptic relatedness is present, under the null hypothesis the variance of Δ~*x*~is a quartic polynomial of allele frequency *p*,

Gorroochurn et al. \[[@B10]\] pointed out that when the population has several subpopulations, Δ~*x*~has a non-zero mean

When the population is of pure CR, the theoretical value of *μ*~*x*~is zero. But in reality the PS and CR are usually mixed together, so it won\'t do any harm if we include this term in our analysis.

Let *B*~1~, *B*~2~, \..., *B*~*K*~be arbitrary *K*null markers with minor allele frequencies *p*~1~, \..., *p*~*K*~. For the *k*-th marker, let be the genotype frequency estimate for genotype *j*in group *i*, *i*= 0, 1, *j*= 0, 1, 2. Then is the analogue of Δ~*x*~for null marker *B*~*k*~. Let be the sample estimate of *p*~*k*~. Then we estimate the coefficients in (4) by minimizing

Denote the estimate of *α*~*i*~by , *i*= 0, 1, 2. Let . The estimates of *β*~*i*~, *i*= 1, 2, 3, 4 in (3) can be calculated by minimizing

Let *p*be the MAF of the candidate marker. Then we can estimate and *μ*~*x*~by

The RGC-corrected Cochran-Armitage\'s trend test with score *x*can then be defined as

The Cochran-Armitage\'s trend tests are more powerful than the Pearson\'s chi-square test if the genetic model or *x*can be correctly specified. When the genetic model is unknown and the score *x*may be subject to misspecification, robust tests such as Pearson\'s chi-square test is preferred. Zheng et al. \[[@B13]\] proposed the following 2-df Pearson\'s chi-square test

where is the estimate of the correlation coefficient of *Z*~0~and *Z*~1~. Combining (7) and (8) together, we therefore, propose the RGC-corrected Pearson\'s chi-square test as

Simulation study
----------------

To assess the validity of the proposed RGC method, we have implemented extensive simulations. Following \[[@B11]\], we use Wright\'s coefficient *F*to measure the correlation due to CR. Since it is difficult to simulate pure CR data, following \[[@B11],[@B12]\] and \[[@B14]\], we employ the following procedure to generate a CR population. Let *p*be the allele frequency of a marker. Assume that there are *L*subpopulations including *a*~1~,⋯, *a*~*L*~cases and *b*~1~, ⋯, *b*~*L*~controls. We first generate *p*~1~, \..., *p*~*L*~independently from the Beta distribution *Beta*((1 - *F*)*p/F*, (1 - *F*)(1 - *p*)/*F*). We then generate *L*subpopulations having allele frequency *p*~1~, \..., *p*~*L*~respectively, assuming that within each subpopulation Hardy-Weinberg equilibrium holds. Finally we mix the *L*subpopulations together. From long run, this mixed population would resemble a pure CR population.

The details of the data generation are as follows. We used two subpopulations in each of our simulation. First we chose an allele frequency *p*of a marker which could be either a candidate marker or a null marker. We generated each of *p*~1~and *p*~2~from the Beta distribution *Beta*((1 - *F*)*p/F*, (1 - *F*)(1 - *p*)/*F*). Let *C*~1~, *C*~2~represent the two subpopulations. We calculated the probabilities *P*(*G*~*i*~\|*C*~*j*~), *i*= 0, 1, 2, *j*= 1, 2 according to HWE. The disease prevalence *k*~*j*~in subpopulation *C*~*j*~was estimated by

We then calculated and , the probabilities of genotype *G*~*i*~in cases and controls in subpopulation *C*~*j*~, by

Next we drew independent genotype counts (*a*~0*j*~, *a*~1*j*~, *a*~2*j*~) of cases and (*b*~0*j*~, *b*~1*j*~, *b*~2*j*~) of controls from multinomial distributions *Mul*() and *Mul*() respectively. We then mixed (*a*~0*j*~, *a*~1*j*~, *a*~2*j*~) and (*b*~0*j*~, *b*~1*j*~, *b*~2*j*~) up to obtain a case-control data set given in Table [1](#T1){ref-type="table"}, with and for *i*= 0, 1, 2.

With this method of generating data, we simulated the cases of *p*= 0.2 and 0.45 where *p*is the minor allele frequency of candidate marker. The frequencies of unlinked null markers were selected randomly with equal probability from \[0.1, 0.5\]. The data for the *K*null markers with the same penetrances *f*~0~= *f*~1~= *f*~2~and a candidate marker with different penetrances *f*~0~, *f*~1~, *f*~2~are independently generated. The number of replicates in each simulation was 10, 000. To avoid the instability of the linear regression, the predictors were centered before to be fitted into the regression \[[@B15]\].

Results
=======

A regression-based genomic control (RGC) method is proposed and applied to association tests other than the additive trend test. This method allows for using arbitrary null markers in the GC correction procedure, in which the variability of the allele frequencies of the null markers is adjusted by linear regression. The method is assessed by extensive simulation results. In addition, the robustness of the proposed method to the errors in selecting null markers is evaluated. We also simulate the power of our method.

Table [2](#T2){ref-type="table"} provides simulated type I error results for the uncorrected, GC and RGC tests. It shows that the uncorrected trend tests have highly inflated type I error and the type I errors of GC-corrected test deviate from the nominal level 0.05 more or less. As can be seen from Table [2](#T2){ref-type="table"} the RGC tests yield almost all the simulated type I errors around 0.05. The only exceptions are when *p*= 0.2, *K*= 200 and *F*is either 0.01 or 0.02 the RGC-corrected *T*~0~test yields p-values 0.063 and 0.065 respectively. This is because *T*~0~uses the count of genotype *AA*only, therefore the sample size for this test is small.

###### 

Type I error of the uncorrected and GC or RGC-corrected tests under *H*~0~: *f*~0~= *f*~1~= *f*~2~(nominal level is 0.05, a = (500, 1500), b = (1500, 500).

  *F*    MAF         *K*   Method        *T*~0~   *T*~1/2~   *T*~1~   
  ------ ----------- ----- ------------- -------- ---------- -------- -------
  0.01   *p*= 0.2    200   Uncorrected   0.350    0.557      0.539    0.509
                           GC            0.032    0.056      0.067    0.045
                           RGC           0.063    0.054      0.052    0.055
                     300   Uncorrected   0.335    0.551      0.532    0.497
                           GC            0.027    0.047      0.057    0.038
                           RGC           0.055    0.053      0.051    0.052
         *p*= 0.45   200   Uncorrected   0.446    0.543      0.486    0.496
                           GC            0.085    0.051      0.035    0.053
                           RGC           0.052    0.052      0.054    0.049
                     300   Uncorrected   0.464    0.550      0.487    0.512
                           GC            0.096    0.049      0.037    0.058
                           RGC           0.051    0.050      0.052    0.051
                                                                      
  0.02   *p*= 0.2    200   Uncorrected   0.473    0.667      0.650    0.633
                           GC            0.026    0.046      0.061    0.040
                           RGC           0.065    0.053      0.052    0.056
                     300   Uncorrected   0.452    0.679      0.662    0.637
                           GC            0.022    0.048      0.060    0.035
                           RGC           0.054    0.050      0.051    0.053
         *p*= 0.45   200   Uncorrected   0.591    0.665      0.612    0.627
                           GC            0.101    0.047      0.038    0.060
                           RGC           0.052    0.053      0.054    0.050
                     300   Uncorrected   0.581    0.663      0.610    0.622
                           GC            0.106    0.047      0.032    0.062
                           RGC           0.051    0.052      0.053    0.052

The frequencies of null markers are randomly selected from \[0.1, 0.5\].

Table [3](#T3){ref-type="table"} presents the simulated power of RGC-corrected tests. From this table, we see that the trend tests with the correct mode of inheritance have optimal power. The Pearson\'s chi-square test has less power but is very robust as to model specifications.

###### 

Power of RGC-corrected tests- nominal level 0.05, *K*= 200, a = (300, 200), b = (200, 300).

  *F*    MAF        Model                                          *T*~0~   *T*~1/2~   *T*~1~   
  ------ ---------- ---------------------------------------------- -------- ---------- -------- -------
  0.01   *p*= 0.2   DOM(*f*~0~= 0.1, *f*~1~= *f*~2~= 0.15)         0.134    0.791      0.857    0.777
                    ADD(*f*~0~= 0.1, *f*~1~= 0.17, *f*~2~= 0.24)   0.401    0.805      0.781    0.734
                    REC(*f*~0~= *f*~1~= 0.1, *f*~2~= 0.2)          0.803    0.378      0.130    0.728
                                                                                                
         *p*= 0.4   DOM(*f*~0~= 0.1, *f*~1~= *f*~2~= 0.15)         0.179    0.704      0.852    0.780
                    ADD(*f*~0~= 0.1, *f*~1~= 0.14, *f*~2~= 0.18)   0.701    0.905      0.856    0.866
                    REC(*f*~0~= *f*~1~= 0.1, *f*~2~= 0.2)          0.995    0.936      0.418    0.990
                                                                                                
  0.02   *p*= 0.2   DOM(*f*~0~= 0.1, *f*~1~= *f*~2~= 0.15)         0.129    0.682      0.767    0.674
                    ADD(*f*~0~= 0.1, *f*~1~= 0.17, *f*~2~= 0.24)   0.362    0.698      0.689    0.636
                    REC(*f*~0~= *f*~1~= 0.1, *f*~2~= 0.2)          0.753    0.333      0.130    0.687
                                                                                                
         *p*= 0.4   DOM(*f*~0~= 0.1, *f*~1~= *f*~2~= 0.15)         0.179    0.704      0.852    0.780
                    ADD(*f*~0~= 0.1, *f*~1~= 0.14, *f*~2~= 0.18)   0.655    0.853      0.811    0.809
                    REC(*f*~0~= *f*~1~= 0.1, *f*~2~= 0.2)          0.987    0.876      0.403    0.974

The frequencies of null markers are randomly selected from \[0.1, 0.5\].

Selection of null markers is an important issue when applying the GC method. The null markers are presumably unlinked to the disease, but in practice some linked loci may be chosen as null markers. To investigate the influence of the inclusion of linked markers in the set of null markers, we allowed the markers to be linked to the disease with probability 2%. Table [4](#T4){ref-type="table"} shows that the linked markers have some effect on the type I error which varies across genetic models. But the RGC method still controls the type I error around the nominal level 0.05.

###### 

Type I error of the uncorrected, GC and RGC-corrected tests when the markers are linked to the disease with probability 2% (nominal level is 0.05, *K*= 200, a = (500, 1500), b = (1500, 500), *F*= 0.02, *f*~2~, *f*~1~, *f*~0~are the penetrances for *AA, Aa, aa*.)

  (*f*~0~, *f*~1~, *f*~2~)   MAF         Method        *T*~0~   *T*~1/2~   *T*~1~   
  -------------------------- ----------- ------------- -------- ---------- -------- -------
  (0.01, 0.02, 0.02)         *p*= 0.2    Uncorrected   0.470    0.673      0.657    0.631
                                         GC            0.021    0.041      0.055    0.035
                                         RGC           0.064    0.051      0.047    0.058
  (0.01, 0.015, 0.02)                    Uncorrected   0.474    0.679      0.656    0.637
                                         GC            0.018    0.042      0.056    0.034
                                         RGC           0.056    0.052      0.051    0.054
  (0.01, 0.01, 0.02)                     Uncorrected   0.473    0.669      0.653    0.630
                                         GC            0.022    0.040      0.054    0.039
                                         RGC           0.063    0.052      0.053    0.055
                                                                                    
  (0.01, 0.02, 0.02)         *p*= 0.45   Uncorrected   0.592    0.668      0.615    0.630
                                         GC            0.098    0.046      0.034    0.062
                                         RGC           0.054    0.051      0.046    0.049
  (0.01, 0.015, 0.02)                    Uncorrected   0.608    0.675      0.619    0.638
                                         GC            0.105    0.045      0.033    0.060
                                         RGC           0.053    0.052      0.053    0.050
  (0.01, 0.01, 0.02)                     Uncorrected   0.598    0.670      0.620    0.631
                                         GC            0.103    0.045      0.034    0.061
                                         RGC           0.049    0.051      0.054    0.048

Discussion
==========

Case-control design is useful in detecting genes related to complex disease. For a case-control sample, if there is population structure and cryptic relatedness, spurious association between disease and genotype can occur due to variance inflation in the statistical tests. The genomic control method proposed by Devlin and Roeder \[[@B11]\] is a simple and effective method for eliminating spurious results caused by cryptic relatedness.

However when applying the GC method to correct for inflation of type I error of general trend test or the Pearson\'s chi-square test, it is required that the null markers are matched with the candidate marker in allele frequencies. This matching limits the applicability of the GC method. In this paper we propose a RGC method to correct for the population stratification effects which allows for use of any null markers. To adjust for the variability of allele frequencies of the null markers we estimate the inflated variance *τ*~*x*~and the noncentral parameter *μ*~*x*~by linear regression. This RGC method can be applied to the Cochran-Armitage\'s trend tests other than the additive trend test, with arbitrary score, the Pearson genotype-based association test and other robust efficiency tests.

Simulation results show that the RGC method can properly correct for the inflation of type I error of trend tests or Pearson\'s chi-square test caused by cryptic relatedness in the population. It is observed that the RGC method is slightly conservative for recessive trend test and anti-conservative for dominant trend test when the minor allele frequency is close to 0. We think that this is due to the instability of linear regression near the boundary of MAF values.

Conclusion
==========

Simulation studies show that the RGC method can effectively correct for the variance inflation caused by cryptic relatedness and is robust to inclusion of linked loci in the selection of null markers.
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Appendix
========

Here, we calculate the variance of Δ~*x*~under population structure and various genetic models. Assume that case-control samples come from *L*subpopulations, which include *a*~1~, ⋯, *a*~*L*~cases and *b*~1~, ⋯, *b*~*L*~controls, respectively. Thus , and *n*~0~+ *n*~1~= *n*. We also assume that individuals from different subpopulations are independent. For each subpopulation, the genotypic frequencies are described by

where *p*~*i*~is the frequency of the allelic *A*~*i*~. Let

Using the results from Devlin and Roeder \[[@B11]\] and Zheng et, al \[[@B12]\], we have

where *p*is the frequency of the allelic *A*.
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